Evaluation of Mitral Valve Insufficiency Under General Anesthesia
NCT ID: NCT05736289
Last Updated: 2023-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2023-02-13
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography
NCT06156592
Haemodynamics of Mitral Regurgitation Reduction
NCT05403840
Evaluation of the Elasticity of the Mitral Valve
NCT06153563
Coronary Physiology Peri-Transcatheter Left-sided Valvular Interventions
NCT05374733
The China Mviv Registry
NCT05925335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Percutaneous mitral valve repair
Patients undergoing percutaneous mitral valve repair under general anesthesia for mitral valve regurgitation.
No interventions assigned to this group
Surgical mitral valve repair or replacement
Patients undergoing surgical mitral valve repair or replacement for mitral valve regurgitation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients (\>18 years)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Denise P. Veelo
Principal Investigator, Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Denise P Veelo, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Amsterdam University Medical Center - University of Amsterdam
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam University Medical Center
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
W22_423
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.